Your shopping cart is empty

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

Check out our free and informative ezines and sign up now

Home > Newsletters > Drug Industry Daily > DOJ Looking Into Relationship Between Novartis, Specialty Pharmacy Over Exjade

Drug Industry Daily

Nov. 8, 2012 | Vol. 11 No. 220

DOJ Looking Into Relationship Between Novartis, Specialty Pharmacy Over Exjade

The DOJ is looking into Novartis’ relationship with Accredo Health Group, handing the specialty pharmacy company a subpoena on dealings related to iron overload drug Exjade.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
Email This Article
RSS
Free Trial
Archives
Sample PDF

Mysterious Deaths Spark FDA Investigation into Eli Lilly’s Anti-Psychotic Drug House Committee Investigates FDA Official’s Sudden Departure House Committee Probes Circumstances of FDA Official’s Sudden Departure India Convenes Panel to Tackle Alleged Corruption Cases at Drugs Authority

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.